Supporting the scientific study of sharks, skates and rays since 1983.
Only one of the vaccines, PCV13, is considered safe for children under the age of 2, This vaccine is important because infants and very young children are at higher risk for several dangerous infections, including pneumonia and bacterial meningitis.
First, the recommendation calls for offering a dose of the PCV13 vaccination, marketed by Pfizer Inc. as Prevnar 13, to adults age 65 or older who have not previously received a pneumococcal vaccine or whose previous vaccination history is unknown.